文献速递食管胃疾病与幽门螺杆菌

人类感染早期阶段携带cag致病岛的幽门螺杆菌基因组与甲基化组变异

Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection.
PubMed 文献 · Gastroenterology · 2017-10-21

在德国12名健康幽门螺杆菌阴性成人中开展随机I/II期观察者盲法安慰剂对照试验,受试者接种候选疫苗或安慰剂后接受幽门螺杆菌菌株BCM-300攻击,对攻击菌株及12周后(1例62周后)分离的12株再分离菌进行单分子实时测序以分析基因组和甲基化组变异。观察到的突变率与既往慢性感染患者一致,未见突变爆发;3株再分离菌丧失cag致病岛功能,疫苗组3株再分离菌获得vacA突变并丧失空泡化活性,甲基化组存在菌株间变异。

要点

  • 观察到的突变率与既往慢性幽门螺杆菌感染患者一致,无突变爆发证据。
  • 3株再分离菌丧失cag致病岛功能,疫苗组3株再分离菌获得vacA突变并丧失空泡化活性。
  • 甲基化组存在菌株间变异,源于编码甲基转移酶基因的相位变异。

核心结论

  • 对完全毒力幽门螺杆菌菌株在12名志愿者中的适应过程分析表明,在无菌株间重组条件下获得的遗传与表观遗传变化频率稳健;幽门螺杆菌大量遗传变异对疫苗开发构成挑战。

研究设计与样本

  • 随机I/II期、观察者盲法、安慰剂对照研究,2008年10月至2010年3月在德国纳入12名健康幽门螺杆菌阴性成人。
  • 受试者接受候选疫苗(n=7)或安慰剂(n=5),随后以幽门螺杆菌菌株BCM-300攻击。
  • 采集活检样本分离幽门螺杆菌,对攻击菌株及12株再分离菌(感染后12周获得,1例为62周后)行单分子实时测序并确定全基因组甲基化模式。
  • 通过AGS细胞白细胞介素8释放(检测cag致病岛功能)、中性红摄取(检测空泡化细胞毒素活性)及黏附试验评估遗传变化的功能效应。

主要发现

  • 观察到的突变率与既往慢性幽门螺杆菌感染患者确定的速率一致,无突变爆发证据。
  • 3株再分离菌丧失cag致病岛功能。
  • 疫苗组3株再分离菌获得空泡化细胞毒素基因vacA突变,导致空泡化活性丧失。
  • 甲基化组存在菌株间变异,源于编码甲基转移酶基因的相位变异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Helicobacter pylori is remarkable for its genetic variation; yet, little is known about its genetic changes during early stages of human infection, as the bacteria adapt to their new environment. We analyzed genome and methylome variations in a fully virulent strain of H pylori during experimental infection. METHODS: We performed a randomized Phase I/II, observer-blind, placebo-controlled study of 12 healthy, H pylori-negative adults in Germany from October 2008 through March 2010. The volunteers were given a prophylactic vaccine candidate (n = 7) or placebo (n = 5) and then challenged with H pylori strain BCM-300. Biopsy samples were collected and H pylori were isolated. Genomes of the challenge strain and 12 reisolates, obtained 12 weeks after (or in 1 case, 62 weeks after) infection were sequenced by single-molecule, real-time technology, which, in parallel, permitted determination of genome-wide methylation patterns for all strains. Functional effects of genetic changes observed in H pylori strains during human infection were assessed by measuring release of interleukin 8 from AGS cells (to detect cag pathogenicity island function), neutral red uptake (to detect vacuolating cytotoxin activity), and adhesion assays. RESULTS: The observed mutation rate was in agreement with rates previously determined from patients with chronic H pylori infections, without evidence of a mutation burst. A loss of cag pathogenicity island function was observed in 3 reisolates. In addition, 3 reisolates from the vaccine group acquired mutations in the vacuolating cytotoxin gene vacA, resulting in loss of vacuolization activity. We observed interstrain variation in methylomes due to phase variation in genes encoding methyltransferases. CONCLUSIONS: We analyzed adaptation of a fully virulent strain of H pylori to 12 different volunteers to obtain a robust estimate of the frequency of genetic and epigenetic changes in the absence of interstrain recombination. Our findings indicate that the large amount of genetic variation in H pylori poses a challenge to vaccine development. ClinicalTrials.gov no: NCT00736476.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Nell S, Estibariz I, Krebes J, et al. Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection. Gastroenterology. 2017. PMID: 29066327. doi:10.1053/j.gastro.2017.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。